Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Scorpion Venom Antiserum - North Africa
- Development stage
- Unknown
- Lead developer
- Premium Serums and Vaccines
- Administration
- Intravenous
01
Overview
Scorpion Venom Antiserum - North Africa (marketed under the brand name ANTISCORP-Premium) is an equine-derived polyvalent antiserum developed by Premium Serums and Vaccines. It is composed of purified, enzyme-refined equine immunoglobulins obtained from the plasma of healthy equines hyperimmunized against the venoms of North African scorpion species, specifically Androctonus amoreuxi and Leiurus quinquestriatus. The antiserum works by binding to and neutralizing the active neurotoxins present in the scorpion venoms, preventing them from interacting with their physiological targets (such as voltage-gated sodium and potassium channels). It is indicated for the treatment of scorpion sting envenomation caused by these North African species, particularly in emergency settings to prevent severe systemic symptoms and potential lethality.
- Brand names
- ANTISCORP-Premium
- Other names
- Combipack of Scorpion Venom Antiserum (North Africa)Scorpion Venom Antiserum (North Africa)
02
Targets
Kir (Inward-rectifier potassium channels)NaV (Voltage-gated sodium channels)
Beyond the preview
Go deeper on Scorpion Venom Antiserum - North Africa.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Scorpion Venom Antiserum - North Africa.